These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 24965170

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Resveratrol via activation of AMPK lowers blood pressure in DOCA-salt hypertensive mice.
    Sun GQ, Li YB, Du B, Meng Y.
    Clin Exp Hypertens; 2015; 37(8):616-21. PubMed ID: 26114354
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. CFTR deficiency aggravates Ang II induced vasoconstriction and hypertension by regulating Ca2+ influx and RhoA/Rock pathway in VSMCs.
    Zhao L, Yuan F, Pan N, Yu Y, Yang H, Liu Y, Wang R, Zhang B, Wang G.
    Front Biosci (Landmark Ed); 2021 Dec 30; 26(12):1396-1410. PubMed ID: 34994155
    [Abstract] [Full Text] [Related]

  • 8. Activation of RhoA and inhibition of myosin phosphatase as important components in hypertension in vascular smooth muscle.
    Seko T, Ito M, Kureishi Y, Okamoto R, Moriki N, Onishi K, Isaka N, Hartshorne DJ, Nakano T.
    Circ Res; 2003 Mar 07; 92(4):411-8. PubMed ID: 12600888
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Volatile anesthetics inhibit angiotensin II-induced vascular contraction by modulating myosin light chain phosphatase inhibiting protein, CPI-17 and regulatory subunit, MYPT1 phosphorylation.
    Qi F, Ogawa K, Tokinaga Y, Uematsu N, Minonishi T, Hatano Y.
    Anesth Analg; 2009 Aug 07; 109(2):412-7. PubMed ID: 19608811
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinase.
    Chung HH, Dai ZK, Wu BN, Yeh JL, Chai CY, Chu KS, Liu CP, Chen IJ.
    Br J Pharmacol; 2010 Jun 07; 160(4):971-86. PubMed ID: 20590592
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. RhoA activation in vascular smooth muscle cells from stroke-prone spontaneously hypertensive rats.
    Moriki N, Ito M, Seko T, Kureishi Y, Okamoto R, Nakakuki T, Kongo M, Isaka N, Kaibuchi K, Nakano T.
    Hypertens Res; 2004 Apr 07; 27(4):263-70. PubMed ID: 15127884
    [Abstract] [Full Text] [Related]

  • 19. Epidermal growth factor induces Ca(2+) sensitization through Rho-kinase-dependent phosphorylation of myosin phosphatase target subunit 1 in vascular smooth muscle.
    Sasahara T, Okamoto H, Ohkura N, Kobe A, Yayama K.
    Eur J Pharmacol; 2015 Sep 05; 762():89-95. PubMed ID: 26004531
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.